April 21, 2023

January 25, 2025

This week’s newsletter included:

• • Ribbon Cutting at Utah Tech for the New Center for Precision Medicine & Functional Genomics

  • Dr. Howard McLeod Appointed Director of the Center for Precision Medicine & Functional Genomics at Utah Tech University

  • Metrodora Institute Advances the Treatment of Complex Neuroimmune Diseases and Accelerates the Path to Cures

  • Metrodora Raises $35M to Fund Research and Patient Treatment

  • Xenocor Completes Oversubscribed $10 Million Series A to Lead the Future of Laparoscopic Visualization

  • Nusano Announces Q1 2025 Opening Date for Medical Radioisotope Production Facility in Utah

  • bioMérieux Receives U.S. FDA 510(k) Clearance for the BioFire® SpotFire® Respiratory (R) Panel Mini

  • 13th Annual Bench to Bedside Competition Results

  • Myriad Genetics and Intermountain Precision Genomics Now Offer Solid Tumor Testing in All 50 States with Latest NY State Certification

  • Utah Racks Up Accolades

  • Governor-Led Trade Mission to France and U.K.

  • New Published Real-World Evidence Shows KidneyIntelX™ Utility

  • 100 Companies Championing Women in Utah

  • Peel Therapeutics Describes Excessive NETosis Induction in Long COVID

  • Matia Mobility Announces 3rd Annual Giveaway for Tek RMD M1 Device

  • Recursion’s Chris Gibson Featured in Life Sciences Leader

  • Opportunity for Early-Stage Founders to Apply for the University of Utah’s Master of Business Creation Program

Featured New Member: Avendium